Annual Scientific Meeting

Low-Risk Crohn's Disease – Do We Need to Do Anything at All?

Speaker(s)

• 

  Kim Isaacs, MD, PhD, FACG

  Professor of Medicine
  University of North Carolina
  Chapel Hill, NC

  Grant/Research Support: AbbVie, Lilly, Pfizer, Takeda
  Data Safety Monitoring Board Member: Janssen

Learning Objectives:

• Define and identify treatment strategies for low-risk Crohn's disease.